Synthesis, Characterization and Physicochemical Properties of an Ibuprofen Pharmaceutical Cocrystal

被引:0
作者
Zhang Shuai-Hua [1 ]
Yang Zhao [2 ]
Zhang Yan [2 ]
Zhou Xing-Tong [2 ]
机构
[1] Qingdao Univ, Coll Pharm, Qingdao 266021, Peoples R China
[2] Qingdao Inst Food & Drug Control, Qingdao 266071, Peoples R China
关键词
cocrystal; ibuprofen; solubility; single crystal; stability; SOLID DISPERSION; SOLUBILITY; BIOAVAILABILITY;
D O I
10.14102/j.cnki.0254-5861.2011-2635
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Pharmaceutical cocrystal, as a new solid modification, has attracted more and more attention, which can improve the solubility and bioavailability of oral drugs. Ibuprofen is classified as a biopharmaceutical classification system class II drug with high permeability but low solubility. The main task of this paper was to improve the physicochemical properties of IBU by designing and systhesizing cocrystals. Ibuprofen-isonicotinamide was prepared by solvent evaporation method combined with ultrasound technology. Solid state characterization by powder X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis and fourier transform infrared spectroscopy showed that a new crystalline phase was successfully formed. Single-crystal X-ray diffraction results showed that hydrogen bonds were formed between ibuprofen and isonicotinamide with the molar ratio of 1:1. The aqueous solubility results showed that the formation of cocrystal increased the solubility twice while did not affect the stability of ibuprofen in simulated gastric fluid. In addition, melting point and bond length theory were used to analyze the product and judged that the product is cocrystal rather than salt.
引用
收藏
页码:1444 / 1450
页数:7
相关论文
共 26 条
[1]  
Asparouhov T., 2014, EUR J MED CHEM, V74, P411
[2]   Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges [J].
Cerreia Vioglio, Paolo ;
Chierotti, Michele R. ;
Gobetto, Roberto .
ADVANCED DRUG DELIVERY REVIEWS, 2017, 117 :86-110
[3]  
Chen Liyuan, 2012, Frontiers of Medicine, V6, P195
[4]   An overview of recent studies on the analysis of pharmaceutical polymorphs [J].
Chieng, Norman ;
Rades, Thomas ;
Aaltonen, Jaakko .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 55 (04) :618-644
[5]   Cocrystals of piroxicam with carboxylic acids [J].
Childs, Scott L. ;
Hardcastle, Kenneth I. .
CRYSTAL GROWTH & DESIGN, 2007, 7 (07) :1291-1304
[6]   Advanced methodologies for cocrystal synthesis [J].
Douroumis, Dennis ;
Ross, Steven A. ;
Nokhodchi, Ali .
ADVANCED DRUG DELIVERY REVIEWS, 2017, 117 :178-195
[7]  
Editor R. H., 2007, MOL PHARM, V4, P299
[8]   Physicochemical and mechanical properties of paracetamol cocrystal with 5-nitroisophthalic acid [J].
Hiendrawan, Stevanus ;
Veriansyah, Bambang ;
Widjojokusumo, Edward ;
Soewandhi, Sundani Nurono ;
Wikarsa, Saleh ;
Tjandrawinata, Raymond R. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 497 (1-2) :106-113
[9]  
Jie L., 2014, ASIAN J PHARM CLIN R, V7, P62
[10]   Bioavailability of indomethacin-saccharin cocrystals [J].
Jung, Min-Sook ;
Kim, Jeong-Soo ;
Kim, Min-Soo ;
Alhalaweh, Amjad ;
Cho, Wonkyung ;
Hwang, Sung-Joo ;
Velaga, Sitaram P. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (11) :1560-1568